BioWednesday Webinar: Enabling AI in Drug Discovery
Registration is now closed. Please email firstname.lastname@example.org to be added to the waitlist.
In collaboration with:
Life science companies are increasingly adopting data engineering technologies (AI/ML) to accelerate drug discovery and development. Within this field, as technology leads to a growing volume of data, we are seeing the emergence of young AI start-ups, an abundance of big deals between early-stage companies and larger pharma companies and those companies developing as service providers with unique technologies. Our BioWednesday Webinar, in collaboration with Stevenage Bioscience Catalyst, will feature a panel of experienced entrepreneurs discussing the different ways that AI can be used to aid successful drug discovery and development, what is needed to optimize these various business models and ultimately how can companies mature innovation in this space to create patient impact faster.
If you are inspired by this topic, then why not check out the session ‘Hope, Hype and Reality of AI in Drug Discovery’ which was an exciting panel discussion at our Genesis Digital 2020 Conference. The recording of this session can be accessed here.
16.00 - Welcome
Alicia Gailliez, One Nucleus
16.05 - Panel Discussion: Enabling AI in Drug Discovery
Chair: Steve Gardner, PrecisionLife Ltd
Fiona Nielsen, Repositive
Peyman Gifani, AI VIVO
Ajay Mistry, Oppilotech Ltd
Jelena Aleksic, PharmEnable
16.55 - Closing remarks
Hugo Villanueva, Stevenage Bioscience Catalyst
17.00 - Close
One Nucleus Members: Free
Non-Members: £50 +VAT
Academics: please contact Alicia